Axsome Therapeutics, Inc.
AXSM
Hisse Senetlerindeki Sıralama
#2366
Axsome Therapeutics, Inc. is a biopharmaceutical company dedicated to... Axsome Therapeutics, Inc. is a biopharmaceutical company dedicated to discovering and advancing innovative treatments for a range of central nervous system (CNS) disorders within the United States. Its robust product pipeline features several promising candidates, including: AXS-05, an investigational therapy currently being developed for major depressive disorder and treatment-resistant depression. This compound is also in Phase III clinical evaluation for Alzheimer's disease agitation and has successfully finished Phase II trials investigating its use for smoking cessation. AXS-07, a novel, orally administered, rapidly-acting investigational medicine that employs multiple mechanisms of action. It has concluded two Phase III studies for the acute treatment of migraine attacks. AXS-12, a selective and potent norepinephrine reuptake inhibitor, which is presently undergoing a Phase III trial for narcolepsy. AXS-14, an oral investigational drug, advancing through Phase III trials for the management of fibromyalgia. Axsome Therapeutics also engages in a research collaboration with Duke University to further assess AXS-05's potential in smoking cessation. The company, established in 2012, has its main offices in New York, New York.
Hisse Fiyatı
$159.65
Son senkronizasyon: 2026-10-20
Piyasa Değeri
$8.36B
Değişim (1 gün)
2.46%
Değişim (1 yıl)
21.51%
Ülke
US
Ticaret Axsome Therapeutics, Inc. (AXSM)
Kategori
Healthcare
Axsome Therapeutics, Inc. (AXSM) için tedavüldeki hisse sayısı
June 2026 itibarıyla tedavüldeki hisse sayısı: 51.50M
Axsome Therapeutics, Inc. şirketinin son finansal raporlarına ve hisse fiyatına göre, mevcut tedavüldeki hisse sayısı 51.50M'dir. December 2023 sonunda şirketin 45.43M tedavüldeki hissesi vardı. Tedavüldeki hisse sayısı genellikle hisse bölünmeleri ve hisse geri alımları ile etkilenir.
Axsome Therapeutics, Inc. (AXSM) için 2013 - 2026 tarihleri arasındaki hisse geçmişi
Her yıl sonunda tedavüldeki hisse sayısı
| Yıl | Tedavüldeki Hisse Sayısı | Değiştir |
|---|---|---|
| 2026 (TTM) | 51.50M | 7.49% |
| 2024 | 47.91M | 5.48% |
| 2023 | 45.43M | 11.73% |
| 2022 | 40.66M | 8.07% |
| 2021 | 37.62M | 1.11% |
| 2020 | 37.21M | 9.37% |
| 2019 | 34.02M | 26.55% |
| 2018 | 26.88M | 18.09% |
| 2017 | 22.76M | 18.87% |
| 2016 | 19.15M | 60.32% |
| 2015 | 11.95M | -6.08% |
| 2014 | 12.72M | 62.59% |
| 2013 | 7.82M | 0.00% |
Benzer şirketler veya rakipler için tedavüldeki hisse sayısı
| Şirket | Tedavüldeki Hisse Sayısı | Fark | Ülke |
|---|---|---|---|
| 253.90M | 393.00% |
US
|
|
| 396.00M | 668.92% |
US
|
|
| 478.91M | 829.91% |
AU
|
|
| - | - |
CH
|
|
| 62.19M | 20.75% |
NL
|
